Position in CRVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$650,639 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
13 quarters on record
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Derivatives in CRVS
reported options exposure · as of Jun 30, 2026CallValue
$2,094,588
CallShares
140,200
PutValue
$301,788
PutShares
20,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,363,916,985 across 292 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in CRVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,788 | 20,200 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $2,094,588 | 140,200 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $650,639 | 44,473 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $3,186,414 | 217,800 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $612,997 | 41,900 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $120,890 | 15,700 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $297,990 | 38,700 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $2,912,886 | 378,297 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $501,646 | 68,066 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $40,472 | 10,118 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $38,796 | 12,200 | Put | Defined | 2025-05-19 | |
| 2025-03-31 | $819,813 | 257,803 | Shares | Defined | 2025-05-19 | |
| 2025-03-31 | $67,734 | 21,300 | Call | Defined | 2025-05-19 | |
| 2024-12-31 | $868,305 | 162,300 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $370,220 | 69,200 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $614,992 | 114,952 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $265,166 | 50,221 | Shares | Defined | 2024-11-15 | |
| 2023-12-31 | $40,647 | 23,095 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $80,420 | 35,118 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $17,014 | 20,775 | Shares | Defined | 2022-11-15 | |
| 2021-12-31 | $24,823 | 10,300 | Put | Defined | 2022-02-15 | |
| 2021-09-30 | $1,655,280 | 342,000 | Call | Defined | 2021-11-16 | |
| 2021-09-30 | $841,855 | 173,937 | Shares | Defined | 2021-11-16 | |
| 2021-09-30 | $412,852 | 85,300 | Put | Defined | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||